WallStreetZenWallStreetZen

NASDAQ: TSBX
Turnstone Biologics Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Turnstone Biologics earnings were -$70.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TSBX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$12.9M, down 24.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TSBX reported annual earnings of -$70.8M, with 28.2% growth.

TSBX earnings history

Current Revenue
$0.0
Current Earnings
-$70.8M
Current Profit Margin
0%

TSBX Return on Equity

Current Company
-131.9%
Current Industry
-2%
Current Market
34.1%
TSBX's Return on Equity (-131.9%)... subscribe to Premium to read more.
High Return on Equity Performance

TSBX undefined

Current Company
-105%
Current Industry
-0.4%
TSBX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TSBX announces earnings.

TSBX undefined

Current Company
-221.67%
Current Industry
5.9%
TSBX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TSBX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TSBX-$68.97M-$70.84MN/A-$3.07
BCLI-$11.31M-$11.62MN/A-$2.31
PMCB$20.25M$12.04MN/A$0.74
CARM-$52.16M-$60.48MN/A-$1.46
SLXN-$12.55M-$16.52MN/A-$26.36
View Top Biotech Stocks

Turnstone Biologics Earnings Reports & History FAQ

What were Turnstone Biologics's earnings last quarter?

Turnstone Biologics (NASDAQ: TSBX) reported Q4 2024 earnings per share (EPS) of -$0.55, up 329.17% year over year. Total TSBX earnings for the quarter were -$12.87 million. In the same quarter last year, Turnstone Biologics's earnings per share (EPS) was $0.24.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.

Is Turnstone Biologics profitable or losing money?

As of the last Turnstone Biologics earnings report, Turnstone Biologics is currently losing money. Turnstone Biologics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$70.84 million, a 28.33% increase year over year.

What was TSBX's earnings growth in the past year?

As of Turnstone Biologics's earnings date in Q2 2025, Turnstone Biologics's earnings has grown year over year. TSBX earnings in the past year totalled -$70.84 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.